Healthcare provider profile · identity verified

Joel P Kalman, MD

Internal Medicine · ROCKVILLE, MD · NPI 1063577310

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	942	291
Amlodipine Besylate	Amlodipine Besylate	544	161
Lisinopril	Lisinopril	404	123
Losartan Potassium	Losartan Potassium	382	118
Levothyroxine Sodium	Levothyroxine Sodium	284	78
Metformin Hcl	Metformin Hcl	231	77
Tamsulosin Hcl	Tamsulosin Hcl	211	76
Atenolol	Atenolol	183	56
Glipizide	Glipizide	175	54
Pantoprazole Sodium	Pantoprazole Sodium	167	55
Simvastatin	Simvastatin	158	47
Gabapentin	Gabapentin	156	58
Metformin Hcl Er	Metformin Hcl	154	53
Hydrochlorothiazide	Hydrochlorothiazide	150	44
Albuterol Sulfate Hfa	Albuterol Sulfate	147	58
Arexvy	Rsvpref3 Antigen/As01e/Pf	124	124
Furosemide	Furosemide	116	39
Metoprolol Tartrate	Metoprolol Tartrate	113	40
Pradaxa	Dabigatran Etexilate Mesylate	111	34
Rosuvastatin Calcium	Rosuvastatin Calcium	107	34
Allopurinol	Allopurinol	104	32
Lovastatin	Lovastatin	102	29
Finasteride	Finasteride	98	29
Metoprolol Succinate	Metoprolol Succinate	93	26
Famotidine	Famotidine	85	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	25
Fluoxetine Hcl	Fluoxetine Hcl	72	21
Jardiance	Empagliflozin	66	24
Terazosin Hcl	Terazosin Hcl	64	17
Clopidogrel	Clopidogrel Bisulfate	63	20
Prednisone	Prednisone	60	41
Alendronate Sodium	Alendronate Sodium	59	18
Alvesco	Ciclesonide	59	25
Mirtazapine	Mirtazapine	58	14
Pravastatin Sodium	Pravastatin Sodium	58	17
Tramadol Hcl	Tramadol Hcl	57	14
Trazodone Hcl	Trazodone Hcl	56	14
Wixela Inhub	Fluticasone Propion/Salmeterol	52	13
Meloxicam	Meloxicam	51	26
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Alprazolam	Alprazolam	45	15
Montelukast Sodium	Montelukast Sodium	45	17
Hydralazine Hcl	Hydralazine Hcl	44	13
Escitalopram Oxalate	Escitalopram Oxalate	43	14
Lorazepam	Lorazepam	43	15
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Spironolactone	Spironolactone	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Azithromycin	Azithromycin	36	27
Ondansetron Odt	Ondansetron	36	14
Pregabalin	Pregabalin	36	suppressed
Potassium Chloride	Potassium Chloride	35	13
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	34	34
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	11
Levetiracetam	Levetiracetam	34	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	33	11
Triamcinolone Acetonide	Triamcinolone Acetonide	33	22
Carvedilol	Carvedilol	32	suppressed
Omeprazole	Omeprazole	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	28
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	31	11
Duloxetine Hcl	Duloxetine Hcl	29	11
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	29	suppressed
Ozempic	Semaglutide	29	suppressed
Clonazepam	Clonazepam	28	11
Warfarin Sodium	Warfarin Sodium	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Sertraline Hcl	Sertraline Hcl	26	11
Azelastine Hcl	Azelastine Hcl	25	11
Lactulose	Lactulose	24	suppressed
Colchicine	Colchicine	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Eliquis	Apixaban	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Fluocinonide	Fluocinonide	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	21
Sure Comfort Pen Needle	Pen Needle, Diabetic	21	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	15
Humulin N Kwikpen	Insulin Nph Human Isophane	17	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Ciclopirox	Ciclopirox Olamine	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Temazepam	Temazepam	14	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Austedo	Deutetrabenazine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Ropinirole Er	Ropinirole Hcl	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error